Tolerability and Safety Profile of a New Brand-Generic Product of Glatiramer Acetate in Iranian Patients with Relapsing-Remitting Multiple Sclerosis: An Observational Cohort Study.

Abolfazli, Roya; Pournourmohammadi, Shirin; Shamshiri, Ahmadreza; Samadzadeh, Sara

Abolfazli, Roya; Pournourmohammadi, Shirin; Shamshiri, Ahmadreza; Samadzadeh, Sara.

Afiliação

Abolfazli R; Neurology Department, Tehran University of Medical Sciences, Amiralam Hospital, Tehran, Iran.
Pournourmohammadi S; Medical Affairs Department, Zahravi Pharmaceutical Company, Tehran, Iran.
Shamshiri A; School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Samadzadeh S; Neurology Department, Tehran University of Medical Sciences, Amiralam Hospital, Tehran, Iran.

Curr Ther Res Clin Exp ; 88: 47-51, 2018.

Article em En | MEDLINE | ID: mdl-29928468

Palavras-chave

adverse drug reaction; efficacy; glatiramer acetate; multiple sclerosis; safety; tolerability

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies Idioma: En Revista: Curr Ther Res Clin Exp Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Irã País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google